MindMaze Therapeutics Holding SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology. MindMaze Therapeutics Holding SA was formerly known as NeuroX Group SA. The company was incorporated in 2025 and is based in Lausanne, Switzerland. Show more

Location: Chemin de Roseneck 5, Lausanne, 1006, Switzerland | Website: https://mindmazetherapeutics.com | Industry: | Sector:

Market Cap

30.15M

52 Wk Range

$1.40 - $4.88

Previous Close

$2.41

Open

$2.42

Volume

4,420

Day Range

$2.35 - $2.49

Enterprise Value

34.19M

Cash

0.00

Avg Qtr Burn

N/A

Insider Ownership

31.52%

Institutional Own.

12.91%

Qtr Updated

06/30/25

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
RLF-TD011 (APR-TD011) Details Epidermolysis bullosa	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.